Compare TOVX & MTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TOVX | MTR |
|---|---|---|
| Founded | 2001 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.4M | 9.7M |
| IPO Year | 2012 | N/A |
| Metric | TOVX | MTR |
|---|---|---|
| Price | $0.24 | $4.86 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $1.00 | N/A |
| AVG Volume (30 Days) | ★ 11.0M | 13.1K |
| Earning Date | 05-13-2026 | 03-31-2026 |
| Dividend Yield | N/A | ★ 4.93% |
| EPS Growth | ★ 89.07 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $22.60 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.16 | $4.03 |
| 52 Week High | $1.50 | $10.42 |
| Indicator | TOVX | MTR |
|---|---|---|
| Relative Strength Index (RSI) | 56.24 | 50.53 |
| Support Level | $0.18 | $4.94 |
| Resistance Level | $0.27 | $5.35 |
| Average True Range (ATR) | 0.03 | 0.19 |
| MACD | 0.00 | -0.02 |
| Stochastic Oscillator | 50.46 | 46.53 |
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.
Mesa Royalty Trust holds net overriding royalty interests in various oil and gas properties located in the: Hugoton field of Kansas, San Juan Basin field of New Mexico, and San Juan Basin Field of Colorado.